Trial Profile
A study to evaluate the co-relation of artery stiffness and hypertension with Cancer progression and mortality in patients treated with sorafenib or sunitinib
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Sunitinib (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Mar 2016 New trial record